戰神商業房地產公司 ACRE 深 滬
已收盤 12-24 16:00:00 美东时间
5.09
0.000
0.00%
華盛通- 最 高5.11
- 今 開5.10
- 成交量 41.63万股
- 最 低 5.02
- 昨 收 5.09
- 總市值 2.80亿
- 52周最高 5.755
- 市盈率 靜 --
- 換手率 0.76%
- 52周最低 3.05
- 委 比 -28.19%
- 總股本 5502.65万
- 歷史最高 12.62
- 量 比 0.55
- 振 幅 1.77%
- 歷史最低 -4.15
- 每 手 1
- 風險率 0.50%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅113%！麦格理首予小马智行“跑赢大市"评级目标价29美元；Roth Capital下调好市多至"卖出"，目标价从906美元降至769美元
今日重点评级关注：HC Wainwright & Co.：维持BioCryst Pharma"买入"评级，目标价从30美元升至32美元；TD Cowen：上调Milestone Pharmaceuticals评级至"买入"，目标价8美元
12-16 09:36
Keefe, Bruyette & Woods Upgrades Ares Comml Real Est to Outperform, Raises Price Target to $5.5
Keefe, Bruyette & Woods analyst Jade Rahmani upgrades Ares Comml Real Est (NYSE:ACRE) from Market Perform to Outperform and raises the price target from $4.75 to $5.5.
12-15 20:44
美股大行评级 | 花旗上调Bilibili目标价升至27美元； 摩根士丹利上调英伟达目标价升至220美元；Ardent Health、Stubhub遭多家大行下调评级
花旗上调Bilibili目标价升至27美元； 摩根士丹利上调英伟达目标价升至220美元；Ardent Health、Stubhub遭多家大行下调评级>>
11-17 10:49
UBS Maintains Neutral on Ares Comml Real Est, Raises Price Target to $5
UBS analyst Douglas Harter maintains Ares Comml Real Est (NYSE:ACRE) with a Neutral and raises the price target from $4.5 to $5.
11-15 01:10
美股大行评级 | CoreWeave、Monday遭美银、小摩等多家大行下调目标价；中金首予Nebius "跑赢大市"评级，目标价143美元
今日重点评级关注：Piper Sandler：维持MeiraGTx Hldgs"超配"评级，目标价从28美元升至30美元；RBC Capital：维持4D Molecular Therapeutics"跑赢大市"评级，目标价从26美元升至32美元
11-12 11:43
Ares Commercial Real Estate shares are trading higher after the company reported better-than-expected Q3 financial results.
Ares Commercial Real Estate shares are trading higher after the company reporte...
11-08 00:57
Earnings Scheduled For November 7, 2025
Companies Reporting Before The Bell • Kiora Pharmaceuticals (NASDAQ:KPRX) is pr...
11-07 19:11
Analysts Conflicted on These Real Estate Names: Ares Commercial (ACRE) and Highwoods Properties (HIW)
Companies in the Real Estate sector have received a lot of coverage today as an...
10-21 20:50
美股大行评级 | 潜在涨幅334.0%！HC Wainwright & Co.上调Inventiva目标价至24美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Inventiva"买入"评级，目标价从20美元升至24美元；摩根大通：维持BioMarin Pharmaceutical"超配"评级，目标价从116美元升至119美元
10-10 11:36
Apollo Commercial Real Estate Finance, Inc. Announces Dates for Third Quarter 2025 Earnings Release and Conference Call
Apollo Commercial Real Estate Finance, Inc. (ARI) announced it will hold a conference call on October 31, 2025, at 10:00 a.m. ET to discuss its Q3 2025 financial results, which will be released on October 30, 2025. Participants must register through the provided link to receive dial-in details. The call will include a review of performance, recent events, and a Q&A session. A replay will be available on ARI's website. ARI is a REIT managed by Apo...
10-07 20:15
